NIH-funded research R01 grant

Understanding how different brain cells are affected by Alzheimer’s disease and aging

Official title: Cell-type specific risk and resilience in Alzheimer’s disease and aging

Funded at Pennsylvania State Univ Hershey Med Ctr · NIH-11084476 · Data updated 2026-11-12

This study is looking at how Alzheimer’s disease affects different brain cells and how age and genetics play a role, using samples from people and mice to find out which cells are more sensitive or resistant to the disease, with the hope of discovering new ways to treat it.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionPennsylvania State Univ Hershey Med Ctr
NIH-funded
Lab location1 site (Hershey, United States)
Project startMay 1, 2021
Project endApril 30, 2026
Funding year2025
Award (this year)$624,205
NIH project number5R01AG072602-03
Project IDNIH-11084476 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals at risk for Alzheimer’s disease, particularly those with a family history or genetic predisposition, as well as older adults experiencing cognitive decline.

Less likely to help

Patients with early-stage Alzheimer's disease who do not have identifiable genetic risk factors or those with other unrelated neurological conditions may not benefit from this research.

What this research studies

This research investigates the varying impacts of Alzheimer’s disease (AD) on different types of brain cells, focusing on how age and genetic factors influence these effects. By examining both human brain samples and mouse models, the study aims to identify specific cell types that are more vulnerable or resilient to AD. The researchers will utilize advanced techniques in systems biology to analyze gene expression changes in these cells, which may reveal important insights into the mechanisms of AD and aging. Ultimately, the goal is to establish cell-type specific signatures that could inform future therapeutic strategies.

Why it matters

Potential benefit: If successful, this research could lead to targeted therapies that better address the specific vulnerabilities of different brain cell types in Alzheimer’s disease.

How similar studies have gone: Previous research has shown promising results in understanding cell-type specific responses in neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Pennsylvania State Univ Hershey Med Ctr
    Hershey, United States
    Active

Researchers

  • Principal investigator: Paul, Anirban — Pennsylvania State Univ Hershey Med Ctr
  • Study coordinator: Paul, Anirban

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.